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Suppression of glucagon secretion in response to 
physiological hypoglycemia or cellular glucoprivation in 
ripglut1;glut2–/– mice. (A) Glycemic profiles during use of 
normoglycemic or hypoglycemic clamps in ripglut1;glut2+/– 
and ripglut1;glut2–/– mice. (B) Plasma glucagon levels mea-
sured at the end of the clamp experiment. Hypoglycemia 
induced an approximately 3-fold increase in plasma gluca-
gon in control mice but no increase in ripglut1;glut2–/– mice. 
(C) Glucagon levels 30 minutes after i.p. injection of NaCl 
or 2-DG. 2-DG induced an approximately 1.7-fold increase 
in plasma glucagon in control mice but no increase in glut2-
null mice. (D) Glucagon levels measured 30 minutes fol-
lowing i.c.v. injection of NaCl or 2-DG. 2-DG induced a 
2.5-fold increase in plasma glucagon in control mice and 
no increase in ripglut1;glut2–/– mice. (B and D) Data are 
indicated as mean ± SD; n = 6–10 for each data point. 
(C) Data are indicated as mean ± SEM of 3 experiments, 
each performed with 6–8 mice. **P < 0.01 for comparison 
between NaCl- and 2-DG–injected groups. #P < 0.05 and 
##P < 0.01 for comparison between NaCl–injected control 
and ripglut1;glut2–/– groups (Student’s t test).
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c-FLI cells in the NTS, the DMNX, and the VMH following 2-DG injections. Mice were injected i.p. with NaCl or 2-DG, and tissues were processed 
2 hours later for c-FLI immunohistochemistry. (A) Representative photos from c-FLI–positive cells at 2 different levels of the NTS and DMNX of 
ripglut1;glut2+/– mice after i.p. injection of NaCl or 2-DG. The positions of the sections were between –7.64 and –7.48 mm relative to the bregma. 
Scale bars: 100 µm. AP, area postrema; cc, central canal. (B) c-FLI–positive cells in the NTS and DMNX of ripglut1;glut2+/–, ripglut1;glut2–/–, and 
pgfapglut2;ripglut1;glut2–/– mice after i.p. injection of NaCl or 2-DG. In glut2-null mice, there is no increase in the number of c-FLI–positive cells 
after 2-DG administration. Transgenic expression of GLUT2 in astrocytes restored the sensitivity of the NTS and DMNX to i.p. 2-DG. (C) c-FLI–
positive cells in the VMH of control, ripglut1;glut2–/–, and pgfapglut2;ripglut1;glut2–/– mice after i.p. injection of NaCl or 2-DG. Data are indicated as 
mean ± SD; n = 6–8 mice for each data point. *P < 0.05, **P < 0.01 for comparison between NaCl- and 2-DG–injected groups (Student’s t test).
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The  glucagon  response  during  a  hypoglycemic  clamp 



















































Expression of GLUT2 in astrocytes of ripglut1;glut2–/– mice 
restores glucagon secretion in response to physiological hypo-
glycemia or cellular glucoprivation. (A) Scheme of the GLUT2 
transgene. (B) Southern blot detection of the 3.8-kb EcoRI 
transgene fragment in the genomic DNA of F1 mice from 3 of the 
4 lines of transgenic mice. (C) Western blot detection of GLUT2 
in whole-brain membranes of pgfapglut2;ripglut1;glut2–/– 
mice. GLUT2 is detected in the brains (B) of lines 3 and 4. 
GLUT2 expression in liver (L) of B6 mice is presented as a 
control. GLUT2 is not detectable by Western blot analysis in 
the brains of B6 or ripglut1;glut2–/– mice, as expected from its 
very low abundance. (D) Immunofluorescence detection in the 
brains of mouse transgenic line 4 of GLUT2 and GFAP. Over-
lay of both types of staining shows expression of transgenic 
GLUT2 in glial cells. Scale bar: 50 µm.
Figure 4
Restoration of glucagon secretion in response to physiological hypoglycemia or 
cellular glucoprivation in pgfapglut2;ripglut1;glut2–/– mice. (A) ripglut1;glut2–/– 
and pgfapglut2;ripglut1;glut2–/– mice were clamped for 3 hours at low (∼2.5 mM) 
or euglycemic (∼5.5 mM) levels and plasma glucagon concentrations mea-
sured at the end of clamping. Hypoglycemia did not increase plasma glucagon 
in ripglut1;glut2–/– mice but induced a 1.7-fold increase in plasma glucagon 
in pgfapglut2;ripglut1;glut2–/– mice. (B) Plasma glucagon levels measured 30 
minutes after i.p. injection of NaCl or 2-DG. 2-DG induced a 2.7-fold increase 
in plasma glucagon in pgfapglut2;ripglut1;glut2–/– mice. Data are indicated as 
mean ± SD; n = 6–10. *P < 0.05 for comparison between euglycemic and hypo-
glycemic clamps or NaCl- and 2-DG–injected groups (Student’s t test).
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Expression of GLUT2 in neurons of ripglut1;glut2–/– 
mice did not restore glucagon secretion in 
response to physiological hypoglycemia or cellu-
lar glucoprivation. (A) Schematic representation of 
the GLUT2 transgene. (B) Western blot analysis 
of GLUT2 expression in total brain membrane of 
psynglut2;ripglut1;glut2–/– transgenic mice. K, kid-
ney. (C) Northern blot analysis of GLUT2 mRNA 
in hypothalamus (H), NTS (N), and whole brains of 
psynglut2;ripglut1;glut2–/– mice, lines 1, 3, 7, and 
9. Higher expression of the transgene mRNA was 
found in lines 1 and 3; these lines were selected 
for subsequent physiological analysis. (D) Plasma 
glucagon levels measured 30 minutes after i.c.v. 
injection of NaCl or 2-DG. Whereas 2-DG induced 
a glucagon response in ripglut1;glut2+/– mice, no 
response was observed in ripglut1;glut2–/– or 
in psynglut2;ripglut1;glut2–/– (line 1) mice. The 
same results were obtained with line 3 mice. 
Data are indicated as mean ± SD; n = 6–8. 
***P < 0.005 for comparison between NaCl- and 
2-DG-injected groups; #P < 0.05 for comparison 
between NaCl-injected control (ripglut1;glut2+/–) 
and ripglut1;glut2–/– or psynglut2;ripglut1;glut2–/– 
groups (Student’s t test). 
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Normal glucagon secretion in response to i.c.v. injection of 2-DG in Sv129, B6D2F1, and Sv129xB6D2F1 mice. Plasma glucagon levels mea-
sured 30 minutes after i.c.v. injection of NaCl or 2-DG in Sv129 (A), B6D2F1 (B), and Sv129xB6D2F1 (C) mice. 2-DG induced a strong increase 
in plasma glucagon levels in each mouse strain. Data are indicated as mean ± SD; n = 6–7 for each data point. *P < 0.05 and **P < 0.01 for 
comparison between NaCl- and 2-DG–injected groups (Student’s t test).
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Abnormal glucagonemia in the fed state but normal glucagon secretion in response to hypoglycemia or 2-DG in ripglut1;glut2–/– mice in the 
C57BL/6 background. (A) Fed glucagon levels were approximately 2-fold higher in male ripglut1;glut2–/–(B6) than in C57BL/6 mice; (B) Fed 
glucagon levels were approximately 2-fold higher in female ripglut1;glut2–/–(B6) than in C57BL/6 mice. The fed hyperglucagonemia of mutant 
mice was reduced to the level found in control mice after ganglionic blockade with chlorisondamine (chlori). Chlorisondamine did not change the 
glucagonemia of control mice. (C) Plasma glucagon levels measured at the end of 3 hours of hypoglycemic (∼2.5 mM) or euglycemic (∼5.5 mM) 
clamps. Hypoglycemia induced an approximately 4-fold increase in glucagon plasma levels in control mice and an approximately 2-fold increase 
in mutant mice. (D) Plasma glucagon levels measured 60 minutes after i.p. injections of NaCl or 2-DG in C57Bl and ripglut1;glut2–/–(B6) mice. 
2-DG induced a 5- and 3-fold increase in plasma glucagon in control and mutant mice, respectively. (E) Plasma glucagon levels measured 30 
minutes after i.c.v. injection of NaCl or 2-DG. 2-DG induced a 5-fold increase in plasma glucagon in C57BL/6 mice and an approximately 3-fold 
increase in mutant mice. Data are indicated as mean ± SD; n = 6–8 for each data point. (C) Data are indicated as mean ± SEM of 3 experiments, 
each performed with 5–6 mice. **P < 0.01 and ***P < 0.005 for comparison between NaCl- and 2-DG–injected groups. #P < 0.05 and ##P < 0.01 
for comparison between NaCl-injected control and ripglut1;glut2–/–(B6) groups (Student’s t test).
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Northern and Western blot and immunofluorescence microscopy analysis. 
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Mechanisms  of  glucose  sensing  and  signal 
transduction.  In Glucokinase and glycemic disease: 
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